What is the Purpose of this Study?
This study focuses on people who have been diagnosed with a pancreatic cyst and will be undergoing a fine needle aspirate to collect a sample of pancreatic cyst fluid as part of their normal medical care. The purpose of the study is to determine whether the PanCystPro test can help doctors in making decisions about treatment and monitoring of pancreatic cysts, which are often difficult to accurately distinguish. The PanCystPro test measures biomarkers on fluid obtained from a pancreatic cyst and reports whether the cyst fluid should be considered non-mucinous or mucinous. Mucinous pancreatic cysts are more likely to progress to cancer, while non-mucinous cysts seldom progress to cancer. Researchers hope that this test can be used to better understand pancreatic cysts and help determine whether further follow-up is required.
Eligibility
- * Patients 18 years of age or older
- * Cross sectional imaging studies demonstrating a pancreatic cyst at least 12 mm in size where fluid sampling can aid in patient's management
- * Written informed consent.
- * The patient will be undergoing EUS with anticipated FNA extraction as part of standard patient care.
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
Cinical Utility Study to Determine Impact of PanCystPro Assay on Physician Decision-Making in the Management of Pancreatic Cystic Lesions